Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Spectra Optia Apheresis System

K-Number: K172590 · 2018-03-02

ApplicantTerumobct, Inc.
Decision Date2018-03-02
Product CodeLKN
DecisionSubstantially Equivalent

Device Summary

Spectra Optia Apheresis System is a medical device manufactured by Terumobct, Inc.. It received FDA 510(k) clearance on 2018-03-02 under approval number K172590. The device is classified under product code LKN. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Spectra Optia Apheresis System?

Spectra Optia Apheresis System is a medical device that received FDA 510(k) clearance on 2018-03-02. It is manufactured by Terumobct, Inc.. The 510(k) number is K172590.

When was Spectra Optia Apheresis System approved by the FDA?

Spectra Optia Apheresis System received FDA 510(k) clearance on 2018-03-02, under approval number K172590.

What company makes Spectra Optia Apheresis System?

Spectra Optia Apheresis System is manufactured by Terumobct, Inc..

What is the FDA product code for Spectra Optia Apheresis System?

The FDA product code for Spectra Optia Apheresis System is LKN.

Related Clinical Trials

NCT01174108 Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells RECRUITING

Related PubMed Literature

PMID: 40624055 Establishment of a clinical workflow for in vivo Raman spectroscopy during head and neck cancer surgery. Scientific reports (2025)

Other Devices by Terumobct, Inc.

K153601Spectra Optia Apheresis System K162365T-Cuff K181049Spectra Optia Apheresis System K183081Spectra Optia Apheresis System

Related Devices (Code: LKN)

K153601Spectra Optia Apheresis SystemTerumobct, Inc. K180615AMICUS Separator System, AMICUS Exchange Kit - Therapeutics, Waste Transfer Set, Blood Component Filter Set With Vented Spike and Luer AdapterFresenius Kabi USA,Llc K181049Spectra Optia Apheresis SystemTerumobct, Inc. K192150AMICUS Separator SystemFresenius Kabi AG K183081Spectra Optia Apheresis SystemTerumobct, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑